Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 6
2004 4
2005 8
2006 6
2007 4
2008 4
2009 4
2010 10
2011 5
2012 7
2013 6
2014 9
2015 12
2016 9
2017 5
2018 6
2019 5
2020 16
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

117 results
Results by year
Filters applied: . Clear all
Page 1
Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study.
Mahil SK, Dand N, Mason KJ, Yiu ZZN, Tsakok T, Meynell F, Coker B, McAteer H, Moorhead L, Mackenzie T, Rossi MT, Rivera R, Mahe E, Carugno A, Magnano M, Rech G, Balogh EA, Feldman SR, De La Cruz C, Choon SE, Naldi L, Lambert J, Spuls P, Jullien D, Bachelez H, McMahon DE, Freeman EE, Gisondi P, Puig L, Warren RB, Di Meglio P, Langan SM, Capon F, Griffiths CEM, Barker JN, Smith CH; PsoProtect study group. Mahil SK, et al. J Allergy Clin Immunol. 2021 Jan;147(1):60-71. doi: 10.1016/j.jaci.2020.10.007. Epub 2020 Oct 16. J Allergy Clin Immunol. 2021. PMID: 33075408 Free PMC article. Clinical Trial.
Clinical Goals and Barriers to Effective Psoriasis Care.
Strober BE, van der Walt JM, Armstrong AW, Bourcier M, Carvalho AVE, Chouela E, Cohen AD, de la Cruz C, Ellis CN, Finlay AY, Gottlieb AB, Gudjonsson JE, Iversen L, Kleyn CE, Leonardi CL, Lynde CW, Ryan C, Theng CT, Valenzuela F, Vender R, Wu JJ, Young HS, Kimball AB. Strober BE, et al. Among authors: valenzuela f. Dermatol Ther (Heidelb). 2019 Mar;9(1):5-18. doi: 10.1007/s13555-018-0279-5. Epub 2018 Dec 21. Dermatol Ther (Heidelb). 2019. PMID: 30578464 Free PMC article.
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials.
Griffiths CE, Reich K, Lebwohl M, van de Kerkhof P, Paul C, Menter A, Cameron GS, Erickson J, Zhang L, Secrest RJ, Ball S, Braun DK, Osuntokun OO, Heffernan MP, Nickoloff BJ, Papp K; UNCOVER-2 and UNCOVER-3 investigators. Griffiths CE, et al. Lancet. 2015 Aug 8;386(9993):541-51. doi: 10.1016/S0140-6736(15)60125-8. Epub 2015 Jun 10. Lancet. 2015. PMID: 26072109 Clinical Trial.
Psoriasis and Mental Health Workshop Report: Exploring the Links between Psychosocial Factors, Psoriasis, Neuroinflammation and Cardiovascular Disease Risk.
Kleyn CE, Talbot PS, Mehta NN, Sampogna F, Bundy C, Ashcroft DM, Kimball AB, van de Kerkhof PCM, Griffiths CEM, Valenzuela F, van der Walt JM, Aberra T, Puig L. Kleyn CE, et al. Among authors: valenzuela f. Acta Derm Venereol. 2020 Jan 7;100(1):adv00020. doi: 10.2340/00015555-3375. Acta Derm Venereol. 2020. PMID: 31742649 Free article. Review.
Adalimumab for severe psoriasis in Chilean paediatric patients.
Armijo Fernandez D, Valenzuela F, Saint-Pierre Contreras G, Cortés González A. Armijo Fernandez D, et al. Among authors: valenzuela f. An Bras Dermatol. 2020 Jan-Feb;95(1):105-106. doi: 10.1016/j.abd.2019.04.012. Epub 2019 Dec 30. An Bras Dermatol. 2020. PMID: 31959513 Free PMC article. No abstract available.
[Chilean guidelines for chronic urticaria].
Aguilera-Insunza R, Correa H, Díaz C, Marinovic MA, Valenzuela F. Aguilera-Insunza R, et al. Among authors: valenzuela f. Rev Med Chil. 2018 Nov;146(11):1334-1342. doi: 10.4067/S0034-98872018001101334. Rev Med Chil. 2018. PMID: 30725048 Free article. Spanish. No abstract available.
Cutaneous lupus erythematosus induced by adalimumab: A case report.
González-Cuevas R, Peruilh-Bagolini L, Valenzuela F, Vargas-Mora P. González-Cuevas R, et al. Among authors: valenzuela f. Dermatol Ther. 2020 Nov;33(6):e14339. doi: 10.1111/dth.14339. Epub 2020 Oct 5. Dermatol Ther. 2020. PMID: 32975341 No abstract available.
Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial.
Bachelez H, van de Kerkhof PC, Strohal R, Kubanov A, Valenzuela F, Lee JH, Yakusevich V, Chimenti S, Papacharalambous J, Proulx J, Gupta P, Tan H, Tawadrous M, Valdez H, Wolk R; OPT Compare Investigators. Bachelez H, et al. Among authors: valenzuela f. Lancet. 2015 Aug 8;386(9993):552-61. doi: 10.1016/S0140-6736(14)62113-9. Epub 2015 Jun 4. Lancet. 2015. PMID: 26051365 Clinical Trial.
117 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page